ஆண்ட்ரூ சைக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ஆண்ட்ரூ சைக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ஆண்ட்ரூ சைக் Today - Breaking & Trending Today
Intercept Pharmaceuticals, inc (ICPT) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Intercept Appoints Andrew Saik as Chief Financial Officer globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Operator Good morning, and welcome to the VYNE Therapeutics conference call to discuss the first-quarter 2021 financial results and update. [Operator instructions] Please be advised that this call is being recorded at the company s request. I will now turn the call over to Michael Wood at LifeSci Advisors. Please go ahead. Michael Wood LifeSci Advisors Managing Director Good morning, everyone, and thank you for joining us. Before we begin formal remarks, let me remind you that some of the information in the press release issued this morning and on this conference call contain forward-looking statements that involve risks, uncertainties and assumptions that are difficult to predict including statements, forecasts and observations regarding future financial operating performance, impacts of the COVID-19 pandemic online and observations regarding ongoing operating expenses and net revenue. These statements include observations associated with commercialization of ....
VYNE Therapeutics Added to Nasdaq Biotechnology Index VYNE Therapeutics Added to Nasdaq Biotechnology Index BRIDGEWATER, N.J., Dec. 16, 2020 VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that it has been selected for inclusion in the NASDAQ Biotechnology Index (Nasdaq: NBI), based on the results of the annual reconstitution of the index announced by Nasdaq on December 11, 2020. The inclusion will become effective prior to the U.S. market open on Monday, December 21, 2020. The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock Market that are classified as either biotechnology or pharmaceutical companies, and is a modified market capitalization weighted index. According to Nasdaq, the NBI is reconstituted annually in December in accordance with a s ....